The Latest Development of Multifunctional Nanopharmaceutical Formulations and Its Application
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 11129
Special Issue Editors
Interests: fabrication of multifunctional pharmaceutical formulations and overcoming barriers in oral/transdermal drug delivery
Special Issue Information
Dear Colleagues,
Due to their high surface area, high saturation solubility and adjustable surface, nanopharmaceuticals, including liposome, polymeric micelles, dendrimers, quantum dots, nanocrystals, etc., have attracted the attention of many researchers in the pharmaceutical fields. Multifunctional agents modified on the surface of various nanoparticles have stimulated the development of pharmaceutical applications, such as passive or active ligands, with both their imaging and therapeutic capabilities, thus allowing simultaneous monitoring and treatment. The rational design and evaluation of multifunctional nanopharmaceuticals with improved drug efficiency, transportation of the drug across physiological barriers and reduced drug-related toxicity will accelerate the development of drugs from lab to clinical applications.
The aim of this Special Issue is to deliver an up-to-date overview on multifunctional nanopharmaceutical formulations fabricated with novel multifunctional agents and technologies, and to explore their applications in the treatment of various diseases via oral, dermal, transdermal and nasal delivery routines, establishing increased effectiveness and safety in drug therapy, among other applications.
Dr. Xiaoqing Miao
Dr. Tongkai Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multifunctional modification
- nanomedicine
- drug delivery
- physiological barriers
- improved bioavailability
- biomedical applications
- microneedles
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
